41. Fussilat/Clearly Explained
I/We begin by the Blessed Name of Allah
The Immensely Merciful to all, The Infinitely Compassionate to everyone.
41:01
a. Ha. Mim.
41:02
a. This is a Revelation from Allah - The One and Only God of everyone and everything.
b. The Immensely Merciful to all, The Infinitely Compassionate to everyone.
41:03
a. This is a Book whose Messages are clearly explained and well spelled-out -
b. Qur’an in Arabic -
c. for a people who understand.
41:04
a. The Qur’an is to be a herald of good news for those who accept its Message, and
b. a warner for those who intentionally deny and belie its Message.
c. And yet most of them turn away in aversion and arrogance,
d. for they do not care to listen to it so as to reflect on its Message.
41:05
a. And they say:
b. ‘Our hearts are in covering from whatever you call us to, and
c. our ears are heavy so we cannot hear you, and
d. there is a barrier - a void - between us and you with regard to the basic concepts of religion.
e. So you do whatever you like according to your religion to please your Allah, and
f. we are going to do as we have always done.
41:06
a. Tell them O The Prophet:
b. ‘Indeed, I am only a human being like anyone of you.
c. However, it is revealed onto me that your elah is only One Elah.
d. So take a straight course to HIM through faith, reverence, and obedience, and
e. seek HIS forgiveness’ for your disbelief and sinful...
This article delves into the profound and transcendent concept of cosmic beauty as it relates to the natural world. Through an exploration of awe-inspiring landscapes, celestial phenomena, and the intricate web of life on Earth, we examine the capacity of nature to evoke deep aesthetic experiences. This multidisciplinary inquiry draws from philosophy, science, and the arts to unravel the profound connection between human consciousness and the cosmic beauty inherent in the universe.
Background: The main aim of treatment of symptomatic fibroids by various modalities including uterine fibroid embolisation is to alleviate symptoms and ultimately improve the quality of life. The efficacy of this modality of treatment in women with significant fibroid burden and large uterine volumes is not clear.
Objective: To determine the change in symptom severity and health-related quality of life among patients who have undergone uterine fibroid embolisation for treatment of symptomatic uterine fibroids.
Setting: Aga Khan University Hospital, Nairobi
Methods: A prospective before and after study (observational) of patients undergoing uterine fibroid embolisation. Prior to embolisation, study participants underwent a pelvic MRI and filled in the Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QoL), a disease-specific symptom and health-related quality of life questionnaire for fibroids. The same questionnaire was administered after one year.
Outcome measures: The main outcome was change in symptom severity score. Secondary outcome measures were change in health-related quality of life (HRQoL) score, the correlation between age, parity, uterine volume, fibroid number and change in the symptom severity and health-related quality of life scores and the incidence of an additional intervention.
Results: Data from 80 study participants were included in the analysis. The mean change (improvement) in the symptom severity score was -29.6(SD±27.1) [95% CI -35.6 to -23.6, P<0.001] with a mean change (improvement) in health-related quality of life score of 35.7(SD±32.7) [95% CI 28.4 to 42.9, P<0.001].There was a significant positive correlation between fibroid number and change in symptom severity score. There was no significant correlation between age, parity, uterine volume and change in symptom severity score. There was a significant positive correlation between parity and change in the health-related quality of life score. There was no significant correlation between age, uterine volume, fibroid number and change in the health-related quality of life score. The incidence of a major and minor surgical intervention during the one year follow-up period was 6.25% and 12.5% respectively.iv
Conclusions: UFE is associated with a statistically significant and clinically useful improvement in symptom severity and health-related quality of life in women with symptomatic fibroid disease and is an effective treatment option of symptomatic fibroids in patients with large myoma burden or large uterine volumes.